my account log out | |
PCSK9(D374T)-LDLR TR-FRET Assay Kit |
Create: 03/08/2018 |
Expired Date: | never |
Category: | Diagnostic equipment [Health&Medical&Pharmaceutical] |
Message: | PCSK9 is a crucial player in the regulation of plasma cholesterol homeostasis. It binds to the ectodomain of hepatic low-density lipid receptor family members: low density lipoprotein receptor (LDLR), very low density lipoprotein receptor (VLDLR), apolipoprotein E receptor (LRP1/APOER) and apolipoprotein receptor 2 (LRP8/APOER2), and promotes their degradation. PCSK9 acts via a non-proteolytic mechanism to enhance the degradation of the hepatic LDLR through a clathrin LDLRAP1/ARH-mediated pathway. May prevent the recycling of LDLR from endosomes to the cell surface or direct it to lysosomes for degradation. The D374T mutation results in higher affinity of PCSK9 for LDLR. https://www.creativebiomart.net/pcsk9d374t-ldlr-tr-fret-assay-kit-465691.htm |
City: | [US] |
Location: | |
Aug 25 2019 | Recombinant Human FGF2, None tagged | 400 | |
Aug 25 2019 | Recombinant Human PVRL2, None tagged | 411 | |
Aug 25 2019 | Recombinant Human PF4, None tagged | 419 | |
Aug 25 2019 | Recombinant Human CXADR, Fc-His tagged | 437 | |
Aug 25 2019 | Recombinant Mouse Cxadr, Fc-His tagged | 446 | |
Aug 25 2019 | Recombinant Human CX3CL1, His tagged | 439 | |
Aug 25 2019 | Recombinant Human CST5, His tagged | 398 | |
Aug 25 2019 | Recombinant Human CPE, Fc tagged | 407 | |
Aug 25 2019 | Recombinant Human Met, Fc-His tagged | 417 | |
Aug 25 2019 | Recombinant Human CEACAM1, His tagged | 413 |
Copyright © toextrade Inc. All rights reserved. Contact us |